Print PDF
2012 Court Decisions Impact the Life Science Industry
January 3, 2013
Chad A. Landmon
Pharmaceutical Compliance Monitor

Axinn partner Chad Landmon's article "2012 Court Decisions Impact the Life Science Industry" was published by Pharmaceutical Compliance Monitor. In the article, Chad addresses how FDA and FTC regulations in 2012 will affect the stem cell industry, the promotion of drug products and the structure of future patent settlements. 

Click here to access the article.

By using the Axinn, Veltrop & Harkrider LLP website with cookies enabled on your browser, you agree to our use of cookies during your browsing experience. Learn more about our privacy policy.